RESMED INC — Director's Dealing 2010

Mar 9, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-03-05

Reporting Person: Gallahue Kieran (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-05	ResMed Common Stock	M	5000	$23.885	Acquired	8223.897	Direct
2010-03-05	ResMed Common Stock	S	5000	$58.87	Disposed	3223.897	Direct
2010-03-05	ResMed Common Stock	M	10000	$23.885	Acquired	13223.897	Direct
2010-03-05	ResMed Common Stock	S	10000	$58.793	Disposed	3223.897	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-05	ResMed Stock Options	$23.885	M	5000	Disposed	2014-09-01	ResMed Common Stock (5000)	Direct
2010-03-05	ResMed Common Stock Options	$23.885	M	10000	Disposed	2014-09-01	ResMed Common Stock (10000)	Direct

Footnotes

F1: Represents first date options became exercisable.

F2: This transaction was executed in multiple trades at prices ranging from $58.60 to $59.235. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F3: This transaction was executed in multiple trades at prices ranging from $58.60 to $59.26. The price reported reflects the weighted average sale price. The reporting person wil provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F4: Trade executed in accordance with 10b5-1 trading plan.